Method and pharmaceutical to treat spinal discs

Details Method and pharmaceutical to treat spinal discs Method and pharmaceutical to treat spinal discs

2009-12-21

2011-11-01

Bland, Layla (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S062000

Reexamination Certificate

active

08048865

ABSTRACT:
Methods for reducing chronic pain caused by a disrupted spinal disc are described. In one method, a physiologically acceptable amount of an injectable is injected into the disc. The injectable is obtained from a stock solution comprising chondroitin sulphate, glucosamine HCl, aqueous solution of dextrose; sodium carboxymethylcellulose, and a buffer substance in quantity to bring the pH of the stock solution to a value above about 6.0. Water is also added to dilute the stock solution. The stock solution may further comprise an anesthetic such as bupivicaine.

REFERENCES:
patent: 5470842 (1995-11-01), Brandley et al.
patent: 6046187 (2000-04-01), Berde et al.
patent: 6255295 (2001-07-01), Henderson et al.
patent: 6335035 (2002-01-01), Drizen et al.
patent: 6476005 (2002-11-01), Petito et al.
patent: 6562873 (2003-05-01), Olejnik et al.
Klein et al,, “Biochemical injection treatment for discogenic low back pain: a pilot study,”The Spine Journal, 3:220-226(2003).
Simon, “Osteoarthritis: A Review,”Clinical Cornerstone, 2(2):26-37 (1999).

Affiliated with

Also associated with

Rating

Method and pharmaceutical to treat spinal discs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and pharmaceutical to treat spinal discs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and pharmaceutical to treat spinal discs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4276741